Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.69 USD | -0.55% | -3.03% | -34.39% |
May. 07 | MoonLake Immunotherapeutics Q1 Net Loss Widens | MT |
May. 07 | MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.39% | 2.51B | |
+10.33% | 115B | |
+12.70% | 106B | |
-4.65% | 24.69B | |
-1.98% | 21.97B | |
-5.61% | 19.27B | |
-11.65% | 17.56B | |
-39.36% | 17.32B | |
+5.87% | 14.03B | |
+32.46% | 12.13B |
- Stock Market
- Equities
- MLTX Stock
- News MoonLake Immunotherapeutics
- MoonLake Immunotherapeutics Says Maintenance of Nanobody Sonelokimab Leads to Further Improvements